Prevention of Postprandial Hyperglycemia by Acarbose May be a Promising Therapeutic Strategy for Reducing the Increased Risk for Cardiovascular Disease

Inclusion Criteria: * Diabetes Mellitus * Age \>/= 18 years * Naive to acarbose (minimum 3 months before inclusion) Exclusion Criteria: * Hypersensitivity to acarbose or any of the excipients * Age \<18 years * Pregnancy and in nursing * Inflammatory bowel disease, colonic ulceration, partial intestinal obstruction or in patients predisposed to intestinal obstruction * Chronic intestinal diseases associated with marked disorders of digestion or absorption * States which may deteriorate as a result of increased gas formation in the intestine, (e.g. Roemheld's syndrome \[an angina pectoris-like syndrome or aggravation of an angina pectoris due to the postprandial filling of the stomach\] and larger hernias) * Hepatic and severe renal impairment (creatinine clearance \<25 mL/min/ 1,73m2)